instat statistical software version 5.0 (GraphPad Software Inc)
90
Structured Review
GraphPad Software Inc
instat statistical software version 5.0
Instat Statistical Software Version 5.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/instat+version+5%2E0+statistic+software/instat+version+3+05/10__1016_slash_j__carpta__2024__100474-124-8-7
Average 90 stars, based on 1 article reviews
Instat Statistical Software Version 5.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/instat+version+5%2E0+statistic+software/instat+version+3+05/10__1016_slash_j__carpta__2024__100474-124-8-7
Average 90 stars, based on 1 article reviews
instat statistical software version 5.0 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Software:Article Title: Carboplatin delays mammary cancer 4T1 growth in mice. Article Snippet: Carboplatin is commonly used to treat a variety of tumors.. We investigated the effects of carboplatin (100 mg/kg) in the development and metastatic dissemination of the 4T1 mice mammary carcinoma.. Carboplatin was able to reduce tumor volume and the number of lung metastases in 50% compared to the control animals. Article Title: Combination therapy with carboplatin and thalidomide suppresses tumor growth and metastasis in 4T1 murine breast cancer model. Article Snippet: Carboplatin, efficient cytostatics for cancer therapy, could induce apoptosis and inhibit the growth of vascular endothelium in several tumor cell lines and xenograft models.. It has been suggested that the antitumor effect of chemotherapy could be increased by combining it with an antiangiogenesis agent in anticancer strategy.. The present study explored the potential to increase the antitumor effect of carboplatin by combining it with thalidomide in mouse 4T1 breast cancer models, and the underlining mechanism was investigated. Control:Article Title: Carboplatin delays mammary cancer 4T1 growth in mice. Article Snippet: Carboplatin is commonly used to treat a variety of tumors.. We investigated the effects of carboplatin (100 mg/kg) in the development and metastatic dissemination of the 4T1 mice mammary carcinoma.. Carboplatin was able to reduce tumor volume and the number of lung metastases in 50% compared to the control animals. Article Title: Combination therapy with carboplatin and thalidomide suppresses tumor growth and metastasis in 4T1 murine breast cancer model. Article Snippet: Carboplatin, efficient cytostatics for cancer therapy, could induce apoptosis and inhibit the growth of vascular endothelium in several tumor cell lines and xenograft models.. It has been suggested that the antitumor effect of chemotherapy could be increased by combining it with an antiangiogenesis agent in anticancer strategy.. The present study explored the potential to increase the antitumor effect of carboplatin by combining it with thalidomide in mouse 4T1 breast cancer models, and the underlining mechanism was investigated. |